These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8877390)

  • 1. Cyclophosphamide-induced immunological tolerance: an overview.
    Mayumi H; Umesue M; Nomoto K
    Immunobiology; 1996 Jul; 195(2):129-39. PubMed ID: 8877390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cyclophosphamide-induced immunological tolerance: an overview].
    Mayumi H
    Nihon Geka Gakkai Zasshi; 1996 Dec; 97(12):1097-108. PubMed ID: 9032788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
    J Immunol; 1990 Sep; 145(5):1303-10. PubMed ID: 2143514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
    J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
    Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of Cyclophosphamide-Induced Transplantation Tolerance in Mice and Its Relationship With the HLA-Haploidentical Bone Marrow Transplantation/Post-Transplantation Cyclophosphamide Platform.
    Mayumi H
    Front Immunol; 2021; 12():744430. PubMed ID: 34659242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed chimerism, heart, and skin allograft tolerance in cyclophosphamide-induced tolerance.
    Zhang QW; Tomita Y; Matsuzaki G; Yoshikawa M; Shimizu I; Nakashima Y; Sueishi K; Nomoto K; Yasui H
    Transplantation; 2000 Sep; 70(6):906-16. PubMed ID: 11014644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide-induced chimera-type tolerance to allografts: an overview of drug-induced immunological tolerance.
    Mayumi H; Tokunaga K
    Fukuoka Igaku Zasshi; 1990 Jan; 81(1):20-39. PubMed ID: 2182492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated T-cell reduction or increased levels of chimerism overcome resistance to cyclophosphamide-induced tolerance in NKT-deficient mice.
    Onzuka T; Tomita Y; Okano S; Shimizu I; Yamada H; Yoshikai Y; Tominaga R
    Scand J Immunol; 2010 Aug; 72(2):106-17. PubMed ID: 20618769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity and difference in the mechanisms of neonatally induced tolerance and cyclophosphamide-induced tolerance in mice.
    Eto M; Mayumi H; Nishimura Y; Maeda T; Yoshikai Y; Nomoto K
    J Immunol; 1991 Oct; 147(8):2439-46. PubMed ID: 1918974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
    J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
    Mayumi H; Good RA
    Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming.
    Maeda T; Eto M; Nishimura Y; Nomoto K; Kong YY; Nomoto K
    Immunology; 1993 Jan; 78(1):113-21. PubMed ID: 8436396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
    Tomita Y; Khan A; Sykes M
    J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
    Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
    Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction.
    Mayumi H; Good RA
    Immunobiology; 1989 Mar; 179(1):86-108. PubMed ID: 2659501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD4 monoclonal antibody reduces the dose of cyclophosphamide required to induce tolerance to H-2 haplotype identical skin allografts in mice.
    Omoto K; Nishimura Y; Nomoto K; Kong YY; Umesue M; Murakami Y; Tomita Y; Nomoto K
    Immunobiology; 1996 Jan; 195(1):16-32. PubMed ID: 8852598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability of cyclophosphamide-induced tolerance to permit engraftment of pluripotent stem cells contained in a moderate number of syngeneic bone marrow cells.
    Yoshikawa M; Tomita Y; Uchida T; Zhang QW; Nomoto K
    Immunobiology; 2000 Apr; 201(5):552-67. PubMed ID: 10834313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.